Oncometabolite d-2HG alters T cell metabolism to impair CD8+ T cell function

G Notarangelo, JB Spinelli, EM Perez, GJ Baker… - Science, 2022 - science.org
Gain-of-function mutations in isocitrate dehydrogenase (IDH) in human cancers result in the
production of d-2-hydroxyglutarate (d-2HG), an oncometabolite that promotes tumorigenesis …

[PDF][PDF] Oncometabolite D-2HG alters T cell metabolism to impair CD8+ T cell function

G Notarangelo, JB Spinelli, EM Perez, GJ Baker… - bookcafe.yuntsg.com
Results Acute and reversible inhibition of CD8+ T cell proliferation, cytotoxicity, and
interferon-g signaling by D-2HG To evaluate the tumor cell–nonautonomous mechanisms by …

[PDF][PDF] Oncometabolite D-2HG alters T cell metabolism to impair CD8+ T cell function

G Notarangelo, JB Spinelli, EM Perez, GJ Baker… - researchgate.net
Results Acute and reversible inhibition of CD8+ T cell proliferation, cytotoxicity, and
interferon-g signaling by D-2HG To evaluate the tumor cell–nonautonomous mechanisms by …

Oncometabolite D-2HG alters T cell metabolism to impair CD8+ T cell function

G Notarangelo, JB Spinelli, EM Perez, GJ Baker… - Science, 2022 - ui.adsabs.harvard.edu
Gain-of-function mutations in isocitrate dehydrogenase (IDH) in human cancers result in the
production of D-2-hydroxyglutarate (D-2HG), an oncometabolite that promotes …

Oncometabolite d-2HG alters T cell metabolism to impair CD8+ T cell function.

G Notarangelo, JB Spinelli, EM Perez… - Science (New York …, 2022 - europepmc.org
Gain-of-function mutations in isocitrate dehydrogenase (IDH) in human cancers result in the
production of d-2-hydroxyglutarate (d-2HG), an oncometabolite that promotes tumorigenesis …

[HTML][HTML] Oncometabolite d-2HG alters T cell metabolism to impair CD8+ T cell function

G Notarangelo, JB Spinelli, EM Perez… - Science (New York …, 2022 - ncbi.nlm.nih.gov
Gain-of-function mutations in isocitrate dehydrogenase (IDH) in human cancers result in the
production of d-2-hydroxyglutarate (d-2HG), an oncometabolite that promotes tumorigenesis …

Oncometabolite d-2HG alters T cell metabolism to impair CD8+ T cell function

G Notarangelo, JB Spinelli, EM Perez, GJ Baker… - paper.sciencenet.cn
Gain-of-function mutations in isocitrate dehydrogenase (IDH) in human cancers result in the
production of D-2-hydroxyglutarate (D-2HG), an oncometabolite that promotes …

Oncometabolite d-2HG alters T cell metabolism to impair CD8+ T cell function

G Notarangelo, JB Spinelli, EM Perez… - … (New York, NY), 2022 - pubmed.ncbi.nlm.nih.gov
Gain-of-function mutations in isocitrate dehydrogenase (IDH) in human cancers result in the
production of d-2-hydroxyglutarate (d-2HG), an oncometabolite that promotes tumorigenesis …

Oncometabolite d-2HG alters T cell metabolism to impair CD8+ T cell function

G Notarangelo, JB Spinelli… - … (New York, NY …, 2022 - utsouthwestern.elsevierpure.com
Gain-of-function mutations in isocitrate dehydrogenase (IDH) in human cancers result in the
production of d-2-hydroxyglutarate (d-2HG), an oncometabolite that promotes tumorigenesis …

[PDF][PDF] Oncometabolite D-2HG alters T cell metabolism to impair CD8+ T cell function

G Notarangelo, JB Spinelli, EM Perez, GJ Baker… - scholar.harvard.edu
Results Acute and reversible inhibition of CD8+ T cell proliferation, cytotoxicity, and
interferon-g signaling by D-2HG To evaluate the tumor cell–nonautonomous mechanisms by …